AIM

ARK Investment Management Portfolio holdings

AUM $13.6B
 

ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.

This Quarter Return
-1.3%
1 Year Return
+94.51%
3 Year Return
+227.41%
5 Year Return
+180.93%
10 Year Return
AUM
$50.3B
AUM Growth
+$50.3B
Cap. Flow
+$14.5B
Cap. Flow %
28.71%
Top 10 Hldgs %
34.7%
Holding
298
New
54
Increased
184
Reduced
49
Closed
8

Sector Composition

1 Healthcare 30.99%
2 Technology 24.52%
3 Communication Services 14.26%
4 Consumer Discretionary 11.94%
5 Financials 3.78%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
OPEN icon
51
Opendoor
OPEN
$3.78B
$247M 0.49%
11,641,318
+7,640,092
+191% +$162M
MCRB icon
52
Seres Therapeutics
MCRB
$162M
$244M 0.48%
11,855,947
-1,885,307
-14% -$38.8M
INCY icon
53
Incyte
INCY
$17B
$243M 0.48%
2,988,149
+1,205,769
+68% +$98M
ACCD
54
DELISTED
Accolade, Inc. Common Stock
ACCD
$241M 0.48%
5,306,902
+2,938,598
+124% +$133M
IONS icon
55
Ionis Pharmaceuticals
IONS
$9.64B
$231M 0.46%
5,142,271
+2,742,717
+114% +$123M
PINS icon
56
Pinterest
PINS
$25.2B
$229M 0.46%
3,094,949
-3,034,831
-50% -$225M
VEEV icon
57
Veeva Systems
VEEV
$44.4B
$219M 0.44%
838,508
+535,879
+177% +$140M
TRMB icon
58
Trimble
TRMB
$18.7B
$219M 0.43%
2,810,249
+1,690,309
+151% +$131M
NSTG
59
DELISTED
NanoString Technologies, Inc.
NSTG
$218M 0.43%
3,314,947
-602,326
-15% -$39.6M
NVDA icon
60
NVIDIA
NVDA
$4.15T
$216M 0.43%
405,115
+222,509
+122% +$119M
HUYA
61
Huya Inc
HUYA
$841M
$214M 0.43%
10,988,392
-612,601
-5% -$11.9M
SDGR icon
62
Schrodinger
SDGR
$1.42B
$195M 0.39%
2,561,846
+1,166,393
+84% +$89M
MELI icon
63
Mercado Libre
MELI
$120B
$189M 0.38%
128,277
+18,638
+17% +$27.4M
CSTL icon
64
Castle Biosciences
CSTL
$673M
$178M 0.35%
2,597,288
+528,696
+26% +$36.2M
SNAP icon
65
Snap
SNAP
$12.3B
$166M 0.33%
3,173,955
-149,548
-4% -$7.82M
CERS icon
66
Cerus
CERS
$251M
$154M 0.3%
25,541,955
-4,030,310
-14% -$24.2M
CDXS icon
67
Codexis
CDXS
$218M
$144M 0.29%
6,281,617
+2,319,511
+59% +$53.1M
KTOS icon
68
Kratos Defense & Security Solutions
KTOS
$10.9B
$143M 0.28%
5,241,941
+3,008,406
+135% +$82.1M
PSNL icon
69
Personalis
PSNL
$430M
$140M 0.28%
5,705,827
-1,072,796
-16% -$26.4M
ADPT icon
70
Adaptive Biotechnologies
ADPT
$1.96B
$140M 0.28%
3,473,910
+1,928,207
+125% +$77.6M
SRPT icon
71
Sarepta Therapeutics
SRPT
$1.98B
$139M 0.28%
1,860,293
+1,617,382
+666% +$121M
BMY icon
72
Bristol-Myers Squibb
BMY
$96.7B
$138M 0.27%
+2,179,919
New +$138M
ARCT icon
73
Arcturus Therapeutics
ARCT
$467M
$138M 0.27%
3,331,889
-627,130
-16% -$25.9M
BABA icon
74
Alibaba
BABA
$325B
$134M 0.27%
590,826
+53,402
+10% +$12.1M
DE icon
75
Deere & Co
DE
$127B
$133M 0.26%
354,282
+106,034
+43% +$39.7M